Zynex receives FDA clearance for next generation NMES device

Zynex announced that it has received clearance from the U.S. FDA for the next generation M-Wave Neuromuscular Electrical Stimulation device. NMES treatments have several uses, including aiding recovery from surgery, managing chronic conditions, and even enhancing exercise performance in healthy individuals. The M-Wave replaces its predecessor, the E-Wave, which has been fundamental in NMES treatments across the U.S. since 1998. The E-Wave was the most powerful and versatile muscle stimulation device on the market for over two decades and the M-Wave builds on that history of performance with a more intuitive design and additional functionality.